Refex Industries Allots 2,73,925 Equity Shares Under ESOP 2021
Refex Industries allots 2,73,925 equity shares under ESOP 2021, increasing share capital from ₹27.37 crore to ₹27.42 crore. Realized ₹1.11 crore from the exercise of options.
The allotment of shares under the ESOP scheme has a limited impact on the company's overall financials.
The announcement highlights the allotment of equity shares to employees under the ESOP scheme, reflecting positive employee engagement and growth prospects.
* Refex Industries Limited has allotted 2,73,925 equity shares of ₹2 each to eligible employees upon exercising their stock options under the Refex Employee Stock Option Scheme 2021. * The Nomination and Remuneration Committee approved the allotment on November 20, 2025. * Consequently, the issued, subscribed, and paid-up equity share capital of the company increased from ₹27,37,11,214 (13,68,55,607 equity shares of ₹2 each) to ₹27,42,59,064 (13,71,29,532 equity shares of ₹2 each). * The money realized by exercise of options is ₹1,11,96,899. * 1,00,00,000 equity shares are covered under Refex Employee Stock Option Scheme 2021.
What to do with a filing like this
Refex Industries Limited filed this with the NSE as a statutory disclosure, categorised under esg reports. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Refex Industries Limited. Read the original for the full detail.